Abiopharma

🔍 NEAL BLIXT DIANNE (Executive)

Company: AMERIPRISE FINANCIAL INC (AMP)

Report Date: 2026-04-29

Detailed Transactions and Holdings:

• Acquired 442 shares of Phantom Stock (Annual) (Derivative)
  Date: 2026-04-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 13,122.61 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each share of phantom stock represents the right to receive one share of Ameriprise Financial, Inc. common stock.
• F2: Upon ceasing to be a non-employee director of Ameriprise Financial, Inc., the reporting director will receive common stock of Ameriprise Financial, Inc. in settlement of the reporting director's deferred share units on a one-for-one basis in a lump sum at the end of the quarter immediately following the quarter in which the reporting director's termination of service on the Board of Directors occurs.